{
    "title": "114_hr2391",
    "content": "The Act titled \"Medicaid Generic Drug Price Fairness Act of 2015\" applies the Medicaid additional rebate requirement to generic drugs. The Medicaid Generic Drug Price Fairness Act of 2015 applies an additional rebate requirement to generic drugs under Section 1927(c)(3) of the Social Security Act. The rebate amount for non-single source or innovator multiple source drugs is increased in a specified manner. The Medicaid Generic Drug Price Fairness Act of 2015 applies an additional rebate requirement to generic drugs under Section 1927(c)(3) of the Social Security Act. The rebate amount for non-single source or innovator multiple source drugs is increased in a specified manner, with special rules for application. The Medicaid Generic Drug Price Fairness Act of 2015 increases rebate requirements for generic drugs under the Social Security Act. The Act modifies references to specific dates and prices for drug rebates. The Medicaid Generic Drug Price Fairness Act of 2015 amends rebate requirements for generic drugs under the Social Security Act by changing references to specific dates and prices for drug rebates. The Medicaid Generic Drug Price Fairness Act of 2015 amends rebate requirements for generic drugs under the Social Security Act by updating references to dates and prices for drug rebates in the last month of a calendar quarter. The Medicaid Generic Drug Price Fairness Act of 2015 updates rebate requirements for generic drugs under the Social Security Act by amending references to dates and prices for drug rebates in the last month of a calendar quarter. The Act defines a drug as either a single source drug or an innovator multiple source drug, with special rules for certain noninnovator multiple source drugs. The Medicaid Generic Drug Price Fairness Act of 2015 updates rebate requirements for generic drugs under the Social Security Act by amending references to dates and prices for drug rebates. Special rules apply to single source drugs, innovator multiple source drugs, and certain noninnovator multiple source drugs. The Act defines an \"applicable quarter\" as the fifth full calendar quarter for certain drugs. The amendments made by the Medicaid Generic Drug Price Fairness Act of 2015 update rebate requirements for generic drugs under the Social Security Act. The term \"applicable quarter\" is defined as the fifth full calendar quarter for drugs not classified as single source or innovator multiple source drugs. These amendments apply to rebate periods starting after December 31, 2014."
}